Search results
6 days ago · Dilip Shanghvi is the chairman and managing director of Sun Pharma. He wrested control of Israel-based Taro Pharma after a bitter three-year battle with Taro's owners. Oct 29, 2010
Jun 12, 2024 · In the dynamic landscape of Indian business, few names evoke as much admiration and respect as Dilip Shanghvi. As the founder of Sun Pharmaceuticals, he stands as a towering figure, not only in the pharmaceutical industry but also in the broader spectrum of Indian entrepreneurship.
Sep 30, 2024 · Overview. Shanghvi is the founder of Sun Pharmaceutical Industries, a generic drugmaker with revenue of $5.4 billion in the year to March 31, 2023. The Mumbai-based company has more than 40...
Jul 8, 2024 · To improve quality standards, we need to build a robust culture: Sun Pharma's Dilip Shanghvi. During the recent Global Pharmaceutical Quality Summit 2024, Shanghvi spoke about navigating supply...
Jan 5, 2024 · Dilip Shanghvi, Founder and Managing Director of India’s most valuable listed pharma outfit – Sun Pharmaceutical Industries, is one of the ‘most interesting and least understood business minds’. By Nichola Marie.
Dec 16, 2023 · Meet Dilip Shanghvi, an Indian billionaire entrepreneur with a staggering net worth of Rs 15.65 lakh Crore, making him the 8th wealthiest individual in the country.
Sep 6, 2024 · Dilip Shanghvi’s story is a testament to visionary leadership and strategic acumen. From humble beginnings to leading a global pharmaceutical powerhouse, his journey continues to...
Dec 19, 2023 · Dilip Shanghvi, our Managing Director, has been recognised by @bsindia as one of the 25 towering business leaders of India for growing Sun Pharma from a one-drug company to a pharma giant...
Sep 3, 2024 · THE ‘RELUCTANT BILLIONAIRE’ is an apt title for the immensely private founder and CMD of Sun Pharmaceutical Industries, Dilip Shantilal Shanghvi. From founding Sun Pharma in 1983 to it becoming the first Indian pharma company to clock $5 billion in valuation, Shanghvi has grown Sun through a series of acquisitions, the biggest of ...
Feb 2, 2024 · Dilip Shanghvi. MD, Sun Pharma. The interim budget exemplifies the government's unwavering dedication to realising its ' Viksit Bharat ' vision. It articulates a forward-thinking and comprehensive approach to development, indicative of the wisdom and foresight of the government.
